Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01569971 · ClinicalTrials.gov registry record

Adolescent, Caregiver, and Young Adult Perspectives of the Transition From Pediatric to Adult Care for Sickle Cell Disease: A Preliminary Evaluation of the Sickle Cell Disease Transition Program

A clinical trial, sponsored by St. Jude Children's Research Hospital.

Completed
Registry status
55
Enrollment target

NCT01569971: Completed study, sponsored by St. Jude Children's Research Hospital.

NCT01569971 is a clinical trial that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 55 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01569971 has completed, sponsored by St. Jude Children's Research Hospital.

COMPLETED
Registry status
55 participants
Enrollment target

Study Summary

Sickle cell disease (SCD) is a debilitating genetic disorder affecting 70,000-100,000 Americans. It is frequently associated with very serious medical complications. For children with SCD, successfully transitioning to adult care is a vital step in ensuring continuity of care, managing their disease, and improving their health outcomes. Transition programs have been created to facilitate the transition process. However, few studies have assessed transition readiness and whether transition program components meet the transition needs of patients and families. The purpose of this study is to explore transitioning from pediatric care to adult care and to assess components of the SJCRH SCD Transition Program from three perspectives: adolescents with SCD, their caregivers, and young adults with SCD who have transitioned to adult care. Data collection methods will include focus groups, questionnaires, and checklists. Qualitative data analysis procedures will be used to examine the data.

Primary Outcome

First, data will be prepared for qualitative analysis. Digital audio files from the focus groups will be transcribed verbatim and questionnaire data will be entered into an Excel data file. Second, focus group data will be qualitatively analyzed using the constant comparative process. A qualitative data analysis program, NVivo9 (Victoria, Australia) will be used to assist with this coding process.

Interventions

  • OTHER Assessment

Trial Details

FieldValue
Enrollment Target 55 participants
Start Date 2012-03
Est. Completion 2014-03

What the finished NCT01569971 record still lists

NCT01569971 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 55 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which Assessment is the first listed.

NCT01569971 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01569971 about?

NCT01569971 is a clinical study titled "Adolescent, Caregiver, and Young Adult Perspectives of the Transition From Pediatric to Adult Care for Sickle Cell Disease: A Preliminary Evaluation of the Sickle Cell Disease Transition Program". Sickle cell disease (SCD) is a debilitating genetic disorder affecting 70,000-100,000 Americans. It is frequently associated with very serious medical complications. For children with SCD, successfully transitioning to adult care is a vital step in ensuring continuity of care, managing their disease...

What is the current status of trial NCT01569971?

This trial is currently completed. The enrollment target is 55 participants. The study started on 2012-03. Estimated completion is 2014-03.

What interventions are being tested in trial NCT01569971?

The interventions under investigation include: Assessment (OTHER).

Who is sponsoring clinical trial NCT01569971?

This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01638676 · 55 participants · Phase 1

    A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients

  • NCT01906385 · 55 participants · Phase 1

    Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)

  • NCT03007030 · 55 participants · Phase 2

    Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery

  • NCT03152058 · 55 participants · Phase 2

    IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01569971, the US trial registry maintained by the National Library of Medicine. NCT01569971 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.